Teva Pharmaceutical Industries Limited (NYSE:TEVA) Q1 2022 Results Conference Call May 3, 2022 8:00 AM ET

Company Participants

Ran Meir - Head, IR

Kåre Schultz - CEO

Eli Kalif - CFO

Sven Dethlefs - Head, North America Commercial

Conference Call Participants

Balaji Prasad - Barclays

David Amsellem - Piper Sandler

Eric Masane - Evercore ISI

Chris Schott - JPMorgan

Elliot Wilbur - Raymond James

Ronny Gal - Bernstein

Gary Nachman - BMO Capital Markets

Bhavin Patel - Bank of America

Operator

Good day, and thank you for standing by, and welcome to Teva's First Quarter 2022 Financial Results Conference Call. At this time, all participants are in a listen-only mode. After the speaker presentation, there will be a question-and-answer session. [Operator Instructions] Please be advised that today's conference is being record it. [Operator Instructions]

I would now like to hand the conference over to your first speaker today, Ran Meir, Senior Vice President, Investor Relations. Please go ahead, sir.

Ran Meir

Thank you, Annette. Thank you, everyone, for joining us today to discuss Teva's first quarter 2022 financial results. We hope you have had an opportunity to review our earnings press release which was issued earlier this morning. A copy of this press release as well as a copy of the slides being presented on this call can be found on our website at tevapharm.com.

Please review our forward-looking statements on Slide number 2. Additional information regarding these statements and our non-GAAP financial measures is available on our earnings release and in our SEC Forms, 10-K and 10-Q.

To begin today's call, Kåre Schultz, Teva's CEO, will provide an overview of the first quarter performance, recent events and priorities going forward. Our CFO, Eli Kalif, will follow up by reviewing the financial results in more detail, including our 2022 financial outlook.

Joining Kåre and Eli on the call today is Sven Dethlefs, Teva's Head of North America Commercial, who will be available during the question-and-answer session that will follow the presentation. Please note that today's call will run approximately one hour.

And with that, I will now turn the call over to Kåre. Kåre, if you would, please?

Kåre Schultz

Thank you. Welcome, everyone. I'm happy to present a solid first quarter of this year, with continued progress on many fronts. If we take a look at the financials, then revenues came in at $3.7 billion, our adjusted EBITDA came in at $1.1 billion and our GAAP diluted loss per share was $0.86 and our non-GAAP diluted EPS came in at $0.55.